XML 51 R15.htm IDEA: XBRL DOCUMENT v3.3.0.814
Note 9 - Segment Information
 6 Months Ended
Sep. 30, 2015
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note
9
-
Segment Information
 
We have four reporting segments: Biological Indicators, Instruments, Continuous Monitoring and Cold Chain. The following tables set forth our segment information (in thousands):
 
 
 
Three Months Ended September 30, 2015
 
 
 
Biological Indicators
 
 
Instruments
 
 
Continuous Monitoring
 
 
Cold Chain
 
 
Total
 
Revenues
   $ 8,482     $ 9,228     $ 2,226     $ 1,840     $ 21,776  
                                         
Gross profit
   $ 5,539     $ 5,705     $ 955     $ 868     $ 13,067  
Selling expenses
     507       1,210       508       63       2,288  
    $ 5,032     $ 4,495     $ 447     $ 805       10,779  
Reconciling items
(1)
                                     (7,986 )
Earnings before income taxes
                                   $ 2,793  
 
 
 
Three Months Ended September 30, 2014
 
 
 
Biological Indicators
 
 
Instruments
 
 
Continuous Monitoring
 
 
Cold Chain
 
 
Total
 
Revenues
   $ 6,441     $ 9,065     $ 3,034     $ --     $ 18,540  
                                         
Gross profit
   $ 4,051     $ 5,455     $ 1,617     $ --     $ 11,123  
Selling expenses
     368       829       145       --       1,342  
    $ 3,683     $ 4,626     $ 1,472     $ --       9,781  
Reconciling items
(1)
                                     (5,038 )
Earnings before income taxes
                                   $ 4,743  
 
 
 
Six Months Ended September 30, 2015
 
 
 
Biological Indicators
 
 
Instruments
 
 
Continuous Monitoring
 
 
Cold Chain
 
 
Total
 
Revenues
   $ 15,718     $ 17,559     $ 4,817     $ 1,840     $ 39,934  
                                         
Gross profit
   $ 10,288     $ 11,060     $ 1,992     $ 868     $ 24,208  
Selling expenses
     867       2,191       966       63       4,087  
    $ 9,421     $ 8,869     $ 1,026     $ 805       20,121  
Reconciling items
(1)
                                     (13,802 )
Earnings before income taxes
                                   $ 6,319  
 
 
Page 12
 
 
 
 
Six Months Ended September 30, 2014
 
 
 
Biological Indicators
 
 
Instruments
 
 
Continuous Monitoring
 
 
Cold Chain
 
 
Total
 
Revenues
   $ 12,858     $ 16,750     $ 5,332     $ --     $ 34,940  
                                         
Gross profit
   $ 7,835     $ 10,382     $ 2,611     $ --     $ 20,828  
Selling expenses
     772       1,821       812       --       3,405  
    $ 7,063     $ 8,561     $ 1,799     $ --       17,423  
Reconciling items
(1)
                                     (9,787 )
Earnings before income taxes
                                   $ 7,636  
 
(1)
Reconciling items include general and administrative, research and development, and other expenses.
 
 
 
 
September 30, 2015
 
 
March 31,
201
5
 
Total assets
                
Biological Indicators
   $ 51,641     $ 36,304  
Instruments
     44,952       44,401  
Continuous Monitoring
     30,339       31,558  
Cold Chain
     20,017       --  
Corporate and administrative
     8,944       5,057  
    $ 155,893     $ 117,320  
 
All long-lived assets are located in the United States except for $4,359,000 and $18,690,000 which are associated with our French and Canadian subsidiaries, respectively.
 
Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):
 
 
 
Three
M
onths
E
nded
September 30
,
 
 
Six Months Ended
September 30,
 
 
 
201
5
 
 
2014
 
 
2015
 
 
2014
 
Net revenues from unaffiliated customers:
                                
United States
   $ 12,529     $ 9,698     $ 24,723     $ 18,189  
Foreign
     9,247       8,842       15,211       16,751  
    $ 21,776     $ 18,540     $ 39,934     $ 34,940  
 
No foreign country exceeds 10% of total revenues other than Canada, which represents 10.6% of revenues for the three months ended September 30, 2015.